Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,470,595
-$93,650 QoQ
Shares Held
134,917
+11.5% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Eversept Partners, LP holds $59,408,307 across 8 Medical Devices names. NVCR ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
143,546 | $30,121,692 | |
| 2 | BBNX |
Beta Bionics, Inc.
|
1,414,838 | $14,176,676 | |
| 3 | GKOS |
GLAUKOS Corp
|
60,214 | $6,482,639 | |
| 4 | BRKR |
Bruker Corp
|
117,013 | $4,226,509 | |
| 5 | NVCR |
NovoCure Ltd
This page
|
134,917 | $1,470,595 | |
| 6 | BVS |
Bioventus Inc.
|
159,110 | $1,452,674 | |
| 7 | INMD |
InMode Ltd.
|
67,744 | $926,737 | |
| 8 | SSII |
SS Innovations International, Inc.
|
110,157 | $550,785 |
All Filings in NVCR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,470,595 | 134,917 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,564,245 | 120,978 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||